Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.61 |
| ▸ | VIPR2 | P41587 | 5/20 | 0.57 |
| ▸ | GLP1R | P43220 | 2/20 | 0.56 |
| ▸ | ECE1 | P42892 | 1/20 | 0.56 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.56 |
| ▸ | GCGR | P47871 | 1/20 | 0.56 |
| ▸ | GIPR | P48546 | 1/20 | 0.56 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.56 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.55 |
| ▸ | NPY2R | P49146 | 4/20 | 0.55 |
| ▸ | NPY4R | P50391 | 4/20 | 0.55 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.55 |
| ▸ | NPY1R | P25929 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30607319 | 0.88 | TFPI (0.71) | TFPIVIPR2GLP1RECE1MUS81 | |
| SCHEMBL30855563 | 0.88 | TFPI (0.56) | TFPIVIPR2VIPR1IL23RNPY2R | |
| SCHEMBL30037828 | 0.87 | VIPR2 (0.65) | TFPIVIPR2GLP1RECE1MUS81 | |
| Mmi-0100 SCHEMBL29380469 | 0.86 | TFPI (0.65) | TFPIVIPR2VIPR1NPY2RNPY4R | |
| SCHEMBL30607476 | 0.86 | TFPI (0.67) | TFPIVIPR2GLP1RECE1MUS81 | |
| SCHEMBL29679632 | 0.86 | TFPI (0.63) | TFPIGLP1RECE1MUS81VIPR1 | |
| SCHEMBL31683267 | 0.86 | TFPI (0.61) | TFPIVIPR2GLP1RECE1MUS81 | |
| SCHEMBL30116708 | 0.86 | VIPR2 (0.60) | TFPIVIPR2GLP1RVIPR1IL23R | |
| SCHEMBL30861920 | 0.86 | TFPI (0.65) | TFPIGLP1RECE1MUS81VIPR1 | |
| SCHEMBL30484712 | 0.86 | TFPI (0.71) | TFPIGLP1RIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230270838-A1 | VACCINE COMPOSITIONS FOR INFLUENZA VIRUSES AND METHODS OF USE | ASCIONE RICHARD (US) | 2023-08-31 | — | — | US | disclosed |